METHODS OF TREATING PROSTATE CANCER

The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MOORE, Marcia Dougan, WANG, Jing, CREW, Andrew P, SNYDER, Lawrence B, HASKELL, III
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R1, R2, R3, X1, X2, X3, X4, and n are defined herein. La présente invention concerne le traitement et/ou la prévention du cancer de la prostate, notamment du cancer de la prostate métastatique et/ou hormono-résistant, chez un sujet ayant besoin d'un traitement, comprenant l'administration d'un composé de formule (I), ou d'un sel, énantiomère, stéréoisomère, solvate, polymorphe, dérivé isotopique ou promédicament pharmaceutiquement acceptable de celui-ci, R1, R2, R3, X1, X2, X3, X4 et n étant tels que définis dans la description.